Use of Acupuncture in the treatment of Dry Mouth and Oral Wounds caused by treatment in patients with head and neck Cancer

Authors
Category Primary study
Registry of TrialsBrazilian Registry of Clinical Trials
Year 2017
INTERVENTION: During the acupuncture technique sterile and disposable needles will be used at 19 P5 points; P9; YNTANG; VG20; B40; IG4; IG11; E 36; E‐3; E‐4; E‐5; E‐6; E‐7; VB‐2; ID‐19; TA‐21; CS‐3; R3; R‐5, all inserted unilaterally, totaling the insertion of 19 disposable needles. Application: Group Case n = 50, acupuncture sessions will be held weekly for four consecutive weeks. The session will last 30 minutes and the needles will be manipulated every five minutes. It will also be used auriculotherapy in the points: Shen‐Men, Central Nervous System, Neurovegetative System, kidney, spleen, pancreas, and mouth. The questionnaires for anamnesis, WHOOQL Life Quality Assessment, BDI, follow‐up and Xerostomia Questionnaire will be applied at the beginning and end of the radiotherapy treatment. Control Group n = 50, the questionnaires for anamnesis, WHOOQL Life Quality Assessment, BDI, follow‐up and Xerostomia Questionnaire will be applied at the beginning and end of the radiotherapy treatment; Acupuncture will not be performed in these patients. dles. H02.004 Procedure/surgery CONDITION: C06.405.205.798 C07.465.815.929 Xerostomia. mucositis ; C06.405.205.798 ; C07.465.815.929 PRIMARY OUTCOME: Primary outcome is the reduction of the patient's xerostomia after treatment. To evaluate the patient's xerostomia, the Xerostomia Inventory and sialometry will be used. To determine if reduction of the xerostomia occurred, the test at the beginning and at the end of the chemotherapy treatment will be compared. It is important to emphasize that the statistical test that is best suited for this evaluation can only be defined after data collection. SECONDARY OUTCOME: Secondary outcomes are not expected INCLUSION CRITERIA: Histopathological diagnosis confirmed squamous cell carcinoma of the head and neck; Age greater than 18 years of age; In need of radiotherapy treatment; Accept participate in the study.
Epistemonikos ID: d696e5f5017230cdcd843a8c199d5e3b84c48660
First added on: Aug 23, 2024